Howard Capital Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Howard Capital Management Group's PFE Position: Q2 2026 in Review
Howard Capital Management Group reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $52.3K and leaving 10,681 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #124.
Howard Capital Management Group first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $566K in Q1 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Howard Capital Management Group held 10,681 shares of Pfizer worth $257K as of Q2 2026.
- Howard Capital Management Group sold 2,000 Pfizer shares in Q2 2026, an estimated $52.3K.
- Pfizer made up 0.02% of Howard Capital Management Group's portfolio in Q2 2026, its #124 holding.
- Howard Capital Management Group first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
- Howard Capital Management Group's Pfizer position peaked at $566K in Q1 2023.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.